Citation Impact
Citing Papers
Genetic and pharmacological inhibition of JNK ameliorates hypoxia-induced retinopathy through interference with VEGF expression
2009
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
The prince and the pauper. A tale of anticancer targeted agents
2008
TSPAN12 Regulates Retinal Vascular Development by Promoting Norrin- but Not Wnt-Induced FZD4/β-Catenin Signaling
2009
MYC on the Path to Cancer
2012 Standout
Differentiation of the brain vasculature: the answer came blowing by the Wnt
2010
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
2013 Standout
The molecular basis of human retinal and vitreoretinal diseases
2010 Standout
Secreted and Transmembrane Wnt Inhibitors and Activators
2012
Ocular Drug Delivery
2010 Standout
Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature
2001 Standout
WNT Signaling in Cardiac and Vascular Disease
2017
Regulation of angiogenesis: apoptotic cues from the ECM
2008
Vascular morphogenesis: a Wnt for every vessel?
2009
Wnt/β-Catenin Signaling and Disease
2012 Standout
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
2010 Standout
Uterine fibroids
2001 Standout
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Use of intravitreal triamcinolone and bevacizumab in Coats' disease with central macular edema
2011
Remodelling the extracellular matrix in development and disease
2014 Standout
A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice
2013
Hereditary Colorectal Cancer
2003 Standout
Anti-Vascular Endothelial Growth Factors Protect Retinal Pigment Epithelium Cells Against Oxidation by Modulating Nitric Oxide Release and Autophagy
2017 Standout
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Therapeutic Targeting of Myc
2010
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Combinatorial Regulation of Endothelial Gene Expression by Ets and Forkhead Transcription Factors
2008
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
Consequences of oxidative stress in age-related macular degeneration
2012
Management of pseudophakic cystoid macular edema
2014
Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells
2008 StandoutNobel
A meta‐analysis of patients with treatment‐resistant macular oedema secondary to retinal vein occlusions following switching to aflibercept
2018
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Pharmacokinetics and Posterior Segment Biodistribution of ESBA105, an Anti–TNF-α Single-Chain Antibody, upon Topical Administration to the Rabbit Eye
2009
Zoladex (goserelin acetate) and the anemic patient: results of a multicenter fibroid study
1996
Cataracts
2017 Standout
Mechanisms of Diabetic Complications
2013 Standout
Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity
2008
Sex cord tumor with annular tubules a distinctive ovarian tumor of the Peutz-Jeghers syndrome
1970
HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410.
1994
Doxycycline-Mediated Inhibition of Choroidal Neovascularization
2009
Works of Christopher M. Andreoli being referenced
Anti-vascular endothelial growth factor therapy for ocular neovascular disease
2007
Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab
2015
Vogt-Koyanagi-Harada Disease
2006
Pre-surgical treatment of uterine myomas with LH-RH agonists.
1992
Endocrine Pathology of the Ovary
1958
The Wnt Signaling Pathway in Familial Exudative Vitreoretinopathy and Norrie Disease
2007